761 Main Avenue
31 articles with Owlstone Medical
Owlstone Medical today announces the appointment of Dr. Richard A Yost to its Scientific Advisory Board.
Investment will fund the global commercialization of Owlstone Medical’s Breath Biopsy® platform for early disease detection and precision medicine
Owlstone Medical Ltd. announced today the addition of Dr Andy Richards CBE to its Board as a Non-Executive Director.
It’s been a busy week for biopharma companies to name a chief executive officer. Over the past week, multiple companies have selected individuals to hold the top spots and guide the growth strategies of their companies.
Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development.
Owlstone Medical Provides Breath Biopsy Services to AstraZeneca to Study Disease Drivers in Asthma and COPD
Owlstone Medical announced it has signed a service agreement with AstraZeneca plc.
Owlstone Medical announced the launch of its Breath Biopsy® Kits, based on the company’s proprietary Breath Biopsy platform.
Owlstone Medical Raises $15 Million USD (£11 million GBP) To Drive Commercialization of Its Breath Biopsy Platform
Owlstone Medical Ltd. announced that it has raised $15 million (£11 million) to drive the global commercialization of its Breath Biopsy® platform.
SBRI Healthcare is delighted to congratulate Owlstone Medical on being named one of three winners of the global Idiopathic Pulmonary Fibrosis Catalyst Challenge.
Owlstone Medical today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000,000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP).
Selected from a short list of nine finalists, out of hundreds of registrants, the winners were announced last night in Chicago as part of the final phase of the Challenge.
Owlstone Medical’s Breath Biopsy Platform Integrated Into GSK's Phase II Respiratory Disease Clinical Trial
Trial will analyze breath biomarkers to improve understanding of the treatment effects of a novel GSK pipeline drug candidate for COPD.
Owlstone Medical’s Disease Breathalyzer, ReCIVA, To Feature In Tomorrow’s World Gallery At The Science Museum, London
Owlstone Medical And Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial To Evaluate Breath Biopsy For Early Detection Of Disease
Owlstone Medical CEO And Breath Biopsy Pioneer Billy Boyle Wins Royal Academy Of Engineering’s Silver Medal
Owlstone Medical Establishes Scientific Advisory Board With Appointment Of Professor Sir Bruce Ponder
Owlstone Medical And Mayo Clinic Collaborate To Develop Pre-Endoscopic Test To Improve Effectiveness Of Colonoscopy